<qa>  What is the most common drug in postmenopausal women?This trial will compare grade 2 or greater late skin toxicities of concomitant letrozole-radiotherapy and radiotherapy followed by letrozole as adjuvant therapy for postmenopausal women with receptor estrogen receptor ER andor progesterone receptor PgR positive tumors. Each drug will be prescribed for 5 years. 